News
U.S. approves first-ever biannual shot to prevent HIV, but getting it might be hard
WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that could protect millions – although it’s unclear how many in the U.S. and abroad will get access to the powerful new option.
The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported ...
The US FDA has approved lenacapavir, a groundbreaking long-acting HIV prevention drug that offers near-complete protection with just two injections per year. Despite its potential, concerns about high ...
A drug currently used to treat ... effectively reducing the risk of HIV infection by 96% and proving 89% more effective than Truvada, a pill taken once a day. The trial was unblinded early ...
However there was a rise of 17% in new HIV diagnoses in the capital. The treatment which has been free on the NHS in England since 2020, involves taking the PrEP pill containing the drugs ...
June 20 (Reuters) - Gilead Sciences (GILD.O), opens new tab said on Thursday a late-stage study showed its long-acting injectable drug ... HIV infection in women compared to its existing daily ...
The Blue Cross Blue Shield of North Carolina campus on University Drive in Durham, N.C. on Friday, January 6, 2023. Robert Willett rwillett@newsobserver.com Thousands of North Carolina residents ...
There’s no cure for HIV or AIDS, but medication slows down virus growth. Most people who take the medication correctly can live a long, healthy life. Single-pill regimens are helpful because ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback